Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Introduction: The standard treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (nCRT). To select patients who would benefit the most from nCRT, there is a need for predictive biomarkers. The aim of this study was to evaluate the role of clinical, pathological, radiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinkovic, Mladen, Stojanovic-Rundic, Suzana, Stanojevic, Aleksandra, Ostojic, Marija, Gavrilovic, Dusica, Jankovic, Radmila, Maksimovic, Natasa, Stroggilos, Rafael, Zoidakis, Jerome, Castellví-Bel, Sergi, Fijneman, Remond J. A., Cavic, Milena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501402/
https://www.ncbi.nlm.nih.gov/pubmed/37719698
http://dx.doi.org/10.3389/fgene.2023.1245594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501402/
https://www.ncbi.nlm.nih.gov/pubmed/37719698
http://dx.doi.org/10.3389/fgene.2023.1245594

Ejemplares similares